Investigation of antifungal susceptibilities and some virulence factors of candida strains isolated from blood cultures and genotyping by RAPD-PCR;Kan Kültürlerinden İzole Edilen Candida Suşlarinda Antifungal Duyarlilig̀in ve Bazi Virülans Faktörlerinin Araştirilmasi ve RAPD-PCR ile Genotiplendirilmesi

Mikrobiyoloji Bulteni

Volumn 45, Issue 2, 2011, Pages 306-317

  Gültekin, Berna ^a   Eyigör, Mete ^a   Tiryaki, Yasin ^a   Kirdar, Sevin ^a   Aydin, Neriman ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Antifungal susceptibility; Biofilm; Candida spp.; Candidemia; Esterase; Genotyping; Phospholipase; RAPD PCR

Indexed keywords

ANTIFUNGAL AGENT; ESTERASE; PHOSPHOLIPASE; VIRULENCE FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOFILM; CANDIDA; CANDIDEMIA; CHILD; CLASSIFICATION; DRUG EFFECT; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFANT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PATHOGENICITY; PRESCHOOL CHILD; RANDOM AMPLIFIED POLYMORPHIC DNA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; CANDIDEMIA; CHILD; CHILD, PRESCHOOL; ESTERASES; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHOSPHOLIPASES; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RETROSPECTIVE STUDIES; VIRULENCE FACTORS; YOUNG ADULT;

EID: 79958712569     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20(1): 133-63. (Pubitemid 46167771)
2. Diekema DJ, Messer SA, Boyken LB, et al. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J Clin Microbiol 2009; 47(10): 3170-7.
3. Tan TY, Tan AL, Tee NW, Ng LS. A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals. Ann Acad Med Singapore 2008; 37(10): 835-40.
4. Altuncu E, Bilgen H, Cerikçiog̀lu N ve ark. Neonatal Candida enfekslyonlan ve etkenlerinin antifungal duyarlihklan. Mikrobiyol Bul 2010; 44(4): 593-603.
5. Gil-Lamaignere C, Roilides E, Hacker), Muller FM. Molecular typing for fungi-a critical review of the possibilities and limitations of currently and future methods. Clin Microbiol Infect 2003; 9(3): 172-85. (Pubitemid 36519089)
6. Akyol V, Çerikçiog̀lu N. Candida parapsilosis klinik izolatlarinin morfotiplendirilmesi, genotiplendirilmesi ve farkli morfotiplerde bazi virülans faktörlerinin araştirilmasi. Mikrobiyol Bul 2010; 44(4): 605-17.
7. Saran B, Karahan ZC, Agirbasli H, Tekeli A, Aksoy AM. Candida albicans klinik izolatlannin "randomly amplified polymorphic DNA" yöntemiyle genotiplendirilmesinde kullanilan farkli primerlerin karşilaştirilmasi. Mikrobiyol Bul 2008; 42(4): 645-54.
8. Chen KW, Lo HJ, Lin YH, Li SY. Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan. J Med Microbiol 2005; 54(Pt 3): 249-58.
9. Costa-de-Oliveira S, Sousa I, Correia A, et al. Genetic relatedness and antifungal susceptibility profile of Candida albicans isolates from fungaemia patients. Med Mycol 2011; 49(3): 248-52.
10. Marol S, Yucesoy M. Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients. Mycoses 2008; 51(1): 40-9. (Pubitemid 350215900)
11. Karkowska-Kuleta J, Rapala-Kozik M, Kozik A. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Acta Biochim Pol 2009; 56(2): 211-24.
12. Dag̀deviren M, Çerikçiog̀lu N, Karavuş M. Hastanede yatan fungemili hastalardan izóle edilen Candida parapsilosis kökenlerinin virülans faktörleri. Türk Mikrobiyol Cem Derg 2003; 33(4): 315-22.
13. Birinci A, Cihan CC, Bilgin K, Acuner C, Durupinar B. Deg̀isik klinik örneklerden izole edilen Candida türlerinde fosfolipaz aktivitesinin araştinlmasi. Mikrobiyol Bul 2005; 39(2): 205-9.
14. Yücesoy M, Marol S. Candida türlerinin esteraz aktivitesinin belirlenmesi. Mikrobiyol Bul 2003; 37(1): 59-63. (Pubitemid 36702407)
15. Donnelly SM, Sullivan DJ, Shanley DB, Coleman DC. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 1999; 145(Pt 8): 1871-82. (Pubitemid 29396917)
16. Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Moet GJ, Jones RN. Comparison of European Committee on Antimicrobial Susceptibility 386 Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for 387 echinocandin susceptibility testing of Candida species.) Clin Microbiol 2010; 48(5): 1592-9.
17. Pfaller MA, Diekema DJ, Andes D, et al; the CLSI Subcommittee for Antifungal Testing. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat 2011. doi:10.1016/j.drup.2011.01.004.
18. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and antifungal resistance in community onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program (2008-2009). Antimicrob Agents Chemother 2011; 55(2): 561-6.
19. Pfaller MA, Diekema DJ, Rex JH, et al. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints, j Clin Microbiol 2006; 44(3): 819-26.
20. Slifkin M. Tween 80 opacity test responses of various Candida species.) Clin Microbiol 2000; 38(12): 4626-8. (Pubitemid 32244560)
21. Samaranayake LP, Raeside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 1984; 22(3): 201-7. (Pubitemid 14075279)
22. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 1982; 20(1): 7-14. (Pubitemid 12161206)
23. Ruzicka F, Hola V, Votava M, Tejkalova R. importance of biofilm in Candida parapsilosis and evaluation of its susceptibility to antifungal agents by colorimetric method. Folia Microbiol (Praha) 2007; 52(3): 209-14. (Pubitemid 47148556)
24. Gülay Z, Ergon C, Ozkütük A, Yücesoy M, Biçmen M. Anestezi yog̀un bakim ünitesi hastalarindan izole edilen Candida albicans suşfarinin antifungal ajanlara duyarlilig̀i ve moleküler epidemiyolojik izlemi. Mikrobiyol Bul 2002; 36(3-4): 309-16.
25. Pfaller MA, Chaturvedi V, Diekema DJ, et al. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. J Clin Microbiol 2008; 46(7): 2155-9.
26. Bertout S, Dunyach C, Drakulovski P, Reynes J, Mallié M. Comparison of the Sensititre YeastOne dilution method with the Clinical Laboratory Standards Institute (CLSI) M27-A3 microbroth dilution reference method for determining MIC of eight antifungal agents on 102 yeast strains. Pathol Biol (Paris) 2011; 59(1): 48-51.
27. Aydin F, Bayramoglu G, Guler NC, Kaklikkaya N, Tosun I. Bloodstream yeast infections in a university hospital in Northeast Turkey: a 4-year survey. Med Mycol 2011; 49(3): 316-9.
28. Gurcuoglu E, Ener B, Akalin H, et al. Epidemiology of nosocomial candidaemia in a university hospital: a 12-year study. Epidemiol Infect 2010; 138(9): 1328-35.
29. Spiliopoulou A, Vamvakopoulou S, Bartzavali C, Dimitracopoulos G, Anastassiou ED, Christofidou M. Eleven-year retrospective survey of candidemia in a University Hospital in Southwestern Greece. Clin Microbiol Infect 2010; 16: 1378-81.
30. Saracli MA, Gumral R, GuI HC, Gonlum A, Yildiran ST. Species distribution and in vitro susceptibility of Candida bloodstream isolates to six new and current antifungal agents in a Turkish tertiary care military hospital, recovered through 2001 and 2006. Mil Med 2009; 174(8): 860-5.
31. Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). Diagn Microbiol Infect Dis 2011; 69(1): 45-50.
32. Diekema DJ. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002; 40(4): 1298-302. (Pubitemid 34279892)
33. Cerikcioglu N, Ilki A, Bilgen H, et al. The relationships between candidemia and candidal colonization and virulence factors of the colonizing strains in preterm infants. Turk J Pediatr 2004; 46(3): 245-50. (Pubitemid 39276582)
34. Sancak B, Menemenliog̀lu D, Aydin NG, Ergüven S, Arikan S. Candida krusei klinik izolatlarinin genomik DNA restriksiyon enzim analizi ve polimeraz zincir reaksiyonu ile tiplendirilmesi. Mikrobiyol Bul 2008; 42(4): 635-44.
35. Kuzucu C, Durmaz R, Otlu B, et al. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey. New Microbiol 2008; 31(3): 401-8.
36. Arslan U, Findik D. Klinik örneklerden izole edilen Candida albicans türü maya mantarlarinda virulans faktörlerinin (proteinaz, slime ve fosfolipaz) in-vitro araştirilmasi. Infeks Derg 2003; 17(4): 471-81.
37. Arikan S, Sancak B, Hasçelik G, Günalp A. Candida albicans izolatlarinda fosfolipaz aktivitesinin saptanmasi. Flora 1998; 3(4): 240-3.
38. Yücesoy M, Yulug̀ N. Candida türlerinde fosfolipaz aktivitesinin araştirilmasi. Infeks Derg 1999; 13(4): 569-74.
39. Fotedar R, Al-Hedaithy SS. Comparison of phospholipase and proteinase activity in Candida albicans and C.dubliniensis. Mycoses 2005; 48(1): 62-7. (Pubitemid 40255404)
40. Yenişehirli G, Bulut Y, Tunçoglu E. Klinik örneklerden izole editen Candida albicans susfannin fosfolipaz, proteinaz ve hemoliz aktiviteleri. Mikrobiyol Bul 2010; 44(1): 71-7.
41. Dolapçi I, Tekell A. Çeşitli Candida türlerinde slime faktörü yapiminin araştirilmasi. Mikrobiyol Bul 2002; 36(3-4): 323-8. (Pubitemid 36701976)
42. Vinitha M, Ballal M. Activity of proteinase, phospholipase and biofilm as virulence markers in Candida species isolated from haematogenous samples. J Hosp Infect 2009; 73(1): 94-5.
43. Shin JH, Kee SJ, Shin MG, et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 2002; 40(4): 1244-8. (Pubitemid 34279883)
44. Demirbilek M, Timurkaynak F, Can F, Azap O, Arslan H. Hastane kaynakh Candida türlerinde biyofilm oluşumu ve antifungal duyarlilik paternleri. Mikrobiyol Bul 2007; 41(2): 261-9.